Bioactive Components of Magical Velvet Beans by Suryawanshi, Suresh S. et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books






Bioactive Components of Magical 
Velvet Beans
Suresh S. Suryawanshi, Prajakta P. Kamble, 
Vishwas A. Bapat and Jyoti P. Jadhav
Abstract
The plant Mucuna is an annual climbing shrub with long vines that can reach 
over fifteen meters in length. About 100–150 Mucuna species are found in the 
tropic and subtropic regions of both hemispheres of the earth. The genus Mucuna 
belongs to the family Leguminosae. It is commonly known as Kewanch, velvet 
bean, cowhage and kappikachhu and is found widely in India as a hardy, herba-
ceous, vigorous, twining annual plant. The size and dimension of the Mucuna 
seeds, pods, platelets and leaves change from species to species. The hair present 
on pods is anthelmintic, which causes itching. People are seeking great attention 
towards Mucuna due to its several medicinal properties, including L-DOPA (L-3, 
4-dihydroxyphenylalanine) along with supplementary antioxidants that are used 
for treating Parkinson’s disease and many neurodegenerative diseases. Thus it is 
being used in about 200 medicinal formulations. The current chapter outlines the 
work that determines the influence of different nutritional, anti-nutritional and 
medicinal values and bioactive agents from different parts of the Mucuna species 
present in India and its importance in medicine.
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1. Introduction
Mucuna is a valuable genus of Leguminosae family; it has tremendous value 
in food and medicine. The genus Mucuna originated in Eastern India and China 
and then was transferred throughout tropical and subtropical regions of the world 
creating new populations [1]. Traditionally, Mucuna is known by different names 
including beans, buffalo beans, dopa bean, cowitch, kappikachhu and atmagupta. 
Out of 100 Mucuna species found worldwide, 8 species and 3 varieties of Mucuna 
are predominantly found in different localities of India [1, 2–4]. The Mucuna plant 
is an annual perennial climbing shrub with long vines having a length of 15–25 m 
with trifoliate leaves and yielding long inflorescences with purple or pale yellow 
flowers. They produce green or brown pods covered with rigid hair, which causes 
intense itching [5]. Pods contain four to six ellipsoidal-shaped seeds that are rich 
dark brown or blotched [6] varying from species to species. Mucuna seeds are a 
rich source of nutritional, antinutritional and phytochemical compounds con-
taining l-dopa as a prime constituent [7]. The content of l-dopa varies between 
from species to species and locality to locality. Among them, M. pruriens is the 
most exploited species as a remedy against Parkinson’s disease [8]. Due to huge 
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international and national trade price and scarcity of M. pruriens, other Mucuna 
species are reported to be adulterants for M. pruriens.
Ancient reports of Ayurveda suggest that Mucuna seed powder contributes 
in reducing the risks of certain cardiovascular diseases and neurodegenerative 
disease and also as a remedy for snake bite. The seeds of Mucuna have gained 
increasing attention among food scientists, nutrition specialists and pharma-
ceutical expertise due to their rich source of antioxidant, phenolic, flavonoids, 
l-dopa, proteins, starch, micronutrients, dietary fiber and bioactive compounds 
that play a pronounced role in the traditional as well as modern medicine all over 
the world [9, 10]. The existing scenario shows ten reported Mucuna species that 
were studied recently by Pulikkalpura et al., from the Indian subcontinent [11], 
whereas Patil et al., also collected fourteen different species of Mucuna from 
various localities and further studied for their l-dopa content (anti-Parkinson’s 
activity) [6, 12].
Mucuna grows best under moist, warm conditions and in areas with plenteous 
rainfall. It can propagate in any type of soil but sandy lome soil is mostly favor-
able with pH of 5.5–7.5. Several researchers have investigated different species 
having typical characteristics like size and shape of bracts, leaflets and pods, 
color, thickness, density as well as number of seeds in pod and flower, respec-
tively [6]. The evaluation of genetic-level studies of Mucuna species from India 
was also carried out using inter-simple sequence repeat markers and randomly 
amplified polymorphic DNA [13]. The seeds show tolerance against different 
abiotic stress including low soil fertility and acidic pH and also grow in wet soils 
(Duke, 1981). Similar to different species, Mucuna also has 2n = 2x = 22 number 
of chromosomes with genome size ranging between 1281 and 1361 Mbp/C [14]. 
Due to wild fluctuating climatic and geographical distribution, these species 
show gigantic diversity in phenotype in the Indian subcontinent. Corresponding 
to the family Leguminosae, it also has the ability of atmospheric nitrogen fixation. 
It is also grown for the potential utility in animal feed and human food due to its 
rich source of nutritional content [15, 16]. Thus, it was consumed universally for 
the treatment of Parkinson’s disease. Traditionally, in Ayurvedic science, Mucuna 
(velvet bean) plant is widely used to treat numerous diseases including parkin-
sonism [17–21] due to its l-dopa content as one of the principal constituents 
[9]. All parts of Mucuna have a great medicinal value in the ancient traditional 
medicinal system, and hence, it has a prodigious demand in the international and 
the Indian market [7, 22].
Mucuna is a superb source of protein and bioactive compounds that have 
increased consumption per capita after being considered as a functional food 
by the US [23]. The previous literature survey shows that the declining occur-
rence of numerous long-lasting disorders, namely neurological disorder, 
cardiovascular diseases, diabetes, obesity and cancer, has a positive correlation 
with the consumption of legume seeds [24]. Considering all the evident health 
profits, studying its bioactive compounds is of great importance. Among all the 
under-utilized Mucuna species, normally available and commonly used Mucuna 
pruriens seeds were studied enormously and have been reported in numerous of 
articles published till date. To avoid the burden on commonly available and used 
Mucuna Purience, various researchers are studying bioactive components and 
the use of other Mucuna species like M. imbracata, M. bracteata, M. monosperma, 
M. macrocarpa, M. sanjappae, M. atropurpurea, M. nigricans, M. gigantea, M. 
pruriens var hirsuta, M. laticifera, M. yadaviana, etc. in the treatment of various 
diseases [5–7, 9, 11–14, 17, 20, 22, 25–34, 49]. Phytochemistry, toxilogicalogy-
cal and food potential on the Mucuna species under study in the world were 
described by Lorenzetti et al. [35].
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2. Bioactive compounds from various parts of Mucuna species
2.1 Bioactive compounds from seeds of Mucuna
Seeds of Mucuna are commonly used part of the plant, which are a rich source of 
nutritional and anti-nutritional compounds like l-dopa (anti-Parkinson’s activity), 
antioxidants, phenolic, flavonoids, tannin, carbohydrates, starch, protein, micronu-
trients Sopanines and many more [9, 12, 26]. Antioxidant activities in this plant are 
mainly due to phenolic and various bioactive compounds present in the seed material 
[36, 37]. There are various extraction techniques, different solvents and processing 
methods that were used to extract the biologically active compounds from the seed 
of Mucuna [26, 31]. The prior study reports that M. macrocarpa, M. sanjappae and 
M. atropurpurea disclosed a higher level of l-dopa content, which also concludes 
that l-dopa content has a positive correlation to the protein content of seeds [12]. 
These high-yielding varieties of Mucuna can be commercially cultivated, which 
can thus serve to be a good option to lower the burden exerted on commonly used 
M. prurience variety [28]. LCMS analysis of four different species demonstrates the 
presence of diverse group of phenolics, alkaloids, flavonoids, different derivatives of 
gallic acid, l-dopa, catechin, alkaloids, quercetin, tannic acid, glycosides, saponins, 
tubastatin and a variety of amino acids in the seed extract [38]. Apart from that, it 
is also concluded that few anticancer compounds like Spergualin, sanggenon G, 
isopentenyl adenosine and spisulosine are also present in the seed extract [28, 38].
2.2 Bioactive compounds from leaves and roots of Mucuna
The root extract of Mucuna has various activities like stimulant, thermogenic, 
purgative, emollient, diuretic anthelmintic, emmenagogue and tonic; hence, they 
are used in the vitiated circumstances in Veda and Ayurveda [39]. l-Dopa content 
of leaves and roots is as much as 1% and 4–7% in Mucuna plant [40]. Mucuna plants 
release secondary chemical compounds called allelochemical in the form of l-3,4-di-
hydroxyphenylalanine (l-dopa) in the surrounding environment which show an 
impact on growth of nearby plants, either negatively or positively. These substances 
are produced through its roots, seeds or leaves [41]. These secondary chemical agents 
play a role in damaging root growth, terminating seedling growth, inhibiting plant-
let growth or suppressing seed germination of other plants [42]. Plant-box bioassay 
explains that the secondary chemical compound produced from the root of Mucuna 
is l-dopa [40], which affects the cell and root of various plant seedlings [41]. Leaf 
extracts are used to treat various complications like Anticataleptic, antiepileptic, 
aphrodisiac, antimicrobial, tonic and ulcers are some applications in which Mucuna 
leaves were reported being used previously [8, 20, 43, 44].
2.3 Bioactive compounds from callus of Mucuna
Production of callus from Mucuna plant material is a new era in the advancement 
of biochemical engineering and industrial biotechnology, which has the potential 
to produce different biologically active agents from the explant [45, 46]. Their 
application in cost-effective industrially important product formation is helpful for 
humankind, which upshots effective drug formulations and upsurges the nutritional 
level of food [47, 48]. l-Dopa is a major component in different parts of Mucuna 
species [9]. This also helps in storing germplasm of endangered species, which in 
turn leads to regenerate new plantlets at any time. Production of callus from Mucuna 
species was done previously by the researcher at the lab scale [49]. An earlier study 
by Chattopadhyay et al. depicted the formation of callus culture of commonly used 
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Mucuna pruriens [50]. Media containing various concentrations of media compo-
nents affects biologically active chemicals and growth of the callus [51, 52]. The use 
of different elicitors and precursors are studied by Nandeo and Patel et al. [53, 54]. 
Implementation of precursor in the media of callus enhances the phenolic content as 
reported in prior studies. The percentage of phenolic is greater in callus culture than 
in seeds, which is very helpful for industrial production [55, 56].
2.4 Bioactive compounds from cell suspension of Mucuna
Reactive oxygen species (ROS) and reactive nitrogen species (RNS) are stress-pro-
ducing free radicals, but at usual level perform an important part in the physiology of 
the body [57] to accommodate the massive demands for l-dopa and other secondary 
metabolites. In vitro production of biologically active compounds from suspension 
culture is predominantly studied before in Mucuna plant by Chattopadhyay et al. 
[50]. The use of mevalonic acid and its precursor gibberellic acid affect the growth. 
l-Dopa in callus exhibits a declining trend in fresh weight with a rise in concentra-
tion of l-dopa as shown by Desai et al. [52]. The comparative study of production of 
l-dopa from cell suspension culture and effect of elicitor on two different species like 
Mucuna pruriens L. and Mucuna prurita H were also done previously [58]. Large-
scale production of phytochemicals and l-dopa was done from Mucuna pruriens L. 
Commercial production of the drugs (l-dopa), phenolic flavonoids and antioxidants 
using cell suspension cultures is in extensive practice nowadays.
3.  Use of different bioactive compounds from Mucuna in various 
application
3.1 Antioxidant activity of Mucuna species
Numerous studies on antioxidant activity and phytoconstituents content of 
Mucuna seeds, leaves and roots were performed previously [4, 7, 19, 30, 31, 59–62]. 
Optimization of different solvents for the extraction of antioxidants was done by 
Aware and Patil et al. [9, 10, 26]. They concluded that depending on solubility of 
antioxidant compounds present in different species of Mucuna, concentration of 
antioxidants differs. Most commonly, ethanolic extract of Mucuna shows good 
antioxidant activity due to high phenolic content [43]. Some reports also conclude 
that water is a universal solvent, which shows significant quantity of phenolic, 
flavonoids and strong antioxidants that can scavenge free radicals using different 
assays. Diseases like neurodegenerative diseases, cardiovascular diseases, aging, 
cancer, rheumatoid arthritis and inflammation are caused by oxidative stresses, 
which are protected by ROS and RNS [60]. LCMS report of four different species 
of Mucuna determines the presence of various components like phenolic, flavo-
noids and bioactive compounds, which are responsible for production of reactive 
species [38].
3.2 Antimicrobial activity of Mucuna species
There are several compounds in Mucuna that contribute for the antimicrobial 
activity as reported in a previous study [38, 43]. These compounds are responsible 
for the treatment of various infectious diseases and ulcers [63]. The study on 
various plant pathogens suggests that methanolic extract of Mucuna pruriens seeds 
showed highest antimicrobial activity [64] from all used solvents. A similar type 
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of study was done by Pujari et al., who concluded that methanol extract of seeds of 
Mucuna pruriens was found to impart the best inhibiting activity among all scruti-
nized pathogens as compared to ethanol and acetone solvents. But alcoholic extract 
of Mucuna pruriens (L.) leaves has significant antioxidant and antibacterial activity, 
which has strongly recommended the use of Mucuna leaves and seed extract in 
traditional as well as modern medicine [65].
3.3 Protective effect against snake venom
Snakebite kills countless people annually since ancient days [66]. Various reports 
show the cross-reactivity between the enzyme of snake venom and protein from 
Mucuna, which determines the activity of Mucuna against snake venom [32, 67–69]. 
Betancur et al. in their review on therapeutics of antisnake venom explain the effec-
tiveness of herbal plants, which act as coadjuvants and thus help to nullify the venom 
toxic action [68]. In recent literature, Kasturiratne et al. studied the global scenario 
of snakebite and deaths. They also elucidate that various traditional medicines were 
sometimes preferred with western drugs [70]. The protective effect of Mucuna in a 
study on mice or rat models proves that it has a good activity for curing snake bite, 
than few reported antivenom [71, 72].
3.4 Anti-Parkinson’s activity of Mucuna species
Parkinson’s disease (PD) was initially discovered by Dr. James Parkinson in 1817. 
It is a chronic neurological disorder triggered by a progressive loss of dopaminergic 
neurons present in the nigrostriatal part of the brain and found to be common in 
the US [73]. The major signs of the disease are complications in body movements, 
speaking, walking and many more complications arise as the disease progresses. 
Anti-Parkinson’s potential of Mucuna is well known from ancient times due to its 
l-dopa content [7, 74]. l-Dopa is a precursor of dopamine used in the treatment of 
neurodegenerative disorders. Various scientists studied the potential of Mucuna 
to produce l-dopa as a source of anti-Parkinson’s drug [8, 19, 75]. l-Dopa with 
other phytochemical compounds has a cumulative effect on the management of 
Parkinson’s disease. Patil et al. describe that there is a correlation among the l-dopa, 
protein and carbohydrate content [12]. Mucuna is a rich source of antioxidant 
compounds, which performs a very important role in the physiology of the body 
mainly functioning in the inhibition of damage occurred because of free radicals 
[76]. There are hundreds of compounds that function as antioxidants in the plant 
system mainly vitamins, polyphenols, enzymes, flavonoids and metals like zinc, 
selenium, etc. [77]. The efficiency of the use of l-dopa and another dopaminergic 
agent in the treatment of Parkinson’s disease is reviewed previously by Koller and 
Rueda [78]. The use of plants for the treatment is more beneficial than chemically 
manufactured medicines due to their infinitesimal occurrence of secondary compli-
cations by routine use and economical feasibility.
3.5 Use of Mucuna species in soil fertility
Cover crops have a role in the nitrogen-fixing bacteria and improvement of soil 
fertility by restoration of soil nutrients. Enormous use of chemical fertilizer and 
water in soil makes soil infertile, to overcome this problem, farmers are implement-
ing traditional methods to enhance soil fertility. Mucuna is one of the best examples 
of a cover crop that has a rich source of biological natural products, which will 
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4. Conclusion
Mucuna is a medicinally and biochemically valuable plant used from ancient 
days, having a large market value due to the presence of a large number of bioactive 
compounds. The content of phytochemical compounds and other bioactive agents 
present in Mucuna fluctuates from species to species. l-Dopa is a chiefly present 
amino acid found abundantly in Mucuna plant, which is used for the treatment 
of Parkinson’s disease. It also contains a great amount of phenolics, flavonoids 
and antioxidants, which play a role in releasing oxidative stress. It also acts as a 
protein-rich diet. Due to all these properties, Mucuna has several applications in the 
pharmaceutical and food industries thereby uplifting the demand of Mucuna in day 
to day life.
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